🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To compare the efficacy and safety of PERT-IJS (Proposed biosimilar Pertuzu...
Status
Terminated
Location
Chopda Medicare & Research Centre Pvt. Ltd,
Start Date
2025-01-06
Trial ID
NCT06038539
This dose-escalating study consists of 3 parts (A, B and C) and will evalua...
Status
Completed
Location
Rigshospitalet, Onkologisk Klinik
Start Date
2011-12
Trial ID
NCT01482377
Treatments Being Tested
This is a Phase Ib/II multi-center, open-label study of HMBD-001 in combina...
Status
Recruiting
Location
GenesisCare North Shore
Start Date
2024-02-05
Trial ID
NCT05910827
This is a multi-site, open-label, dose-finding study, consisting of Parts 1...
Status
Recruiting
Location
UCLA Hematology Oncology - Main Site
Start Date
2025-09-22
Trial ID
NCT07111520
This phase II study will be conducted in two parts (Ⅱa and Ⅱb), with a 21-d...
Status
Recruiting
Location
Shanghai East Hospital
Start Date
2024-09-27
Trial ID
NCT06194656
This is the first study to test Sym013 (Pan-HER) in humans. The primary pur...
Status
Terminated
Location
Vanderbilt University Medical Center
Start Date
2016-11-01
Trial ID
NCT02906670
Treatments Being Tested
This clinical trial is evaluating a drug called HMBD-001 (an anti-HER3 mono...
Status
Active Not Recruiting
Location
Royal Marsden NHS Foundation Trust
Start Date
2021-11-10
Trial ID
NCT05057013
Treatments Being Tested